CheckMyRecalls

Granules Pharmaceuticals Inc. recalls Metformin Hydrochloride…

Granules Pharmaceuticals Inc. recalls Metformin Hydrochloride Extended-Release Tablets

Published
15 Jan 2025
Units affected
6,804 bottles
Agency
FDA
Country
United States

The hazard

Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000-count bottles, Rx Only, Manufactured by: Granules India Limited, Hyderabad- 500 081, India, Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Grand Cayman Islands, NDC 82009-117-10

Brand / company
Granules Pharmaceuticals Inc.
Codes / lots
Lot #: 4911311A, Exp. Date: 11/2025
Distribution
Distributor in OH.
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 15 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.